BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34711458)

  • 1. Central Nervous System Metastases.
    Nieblas-Bedolla E; Zuccato J; Kluger H; Zadeh G; Brastianos PK
    Hematol Oncol Clin North Am; 2022 Feb; 36(1):161-188. PubMed ID: 34711458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Metastases and Leptomeningeal Disease.
    Kumthekar P; Le Rhun E
    Continuum (Minneap Minn); 2023 Dec; 29(6):1727-1751. PubMed ID: 38085896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis to the Central Nervous System.
    Boire A
    Continuum (Minneap Minn); 2020 Dec; 26(6):1584-1601. PubMed ID: 33273173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes for pediatric patients receiving radiotherapy for solid tumor central nervous system metastases.
    Howard TP; Boyle PJ; Marcus KJ; Haas-Kogan DA; Liu KX
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29331. PubMed ID: 34569132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of central nervous system metastases from breast cancer.
    Chang EL; Lo S
    Oncologist; 2003; 8(5):398-410. PubMed ID: 14530493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastases to the central nervous system: Molecular basis and clinical considerations.
    Wanleenuwat P; Iwanowski P
    J Neurol Sci; 2020 May; 412():116755. PubMed ID: 32120132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
    Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
    J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update.
    Ramakrishna N; Anders CK; Lin NU; Morikawa A; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Franzoi MAB; Kirshner JJ; Krop IE; Patt DA; Perlmutter J; Giordano SH
    J Clin Oncol; 2022 Aug; 40(23):2636-2655. PubMed ID: 35640075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the neurologist in the diagnosis and treatment of brain metastases and carcinomatous meningitis.
    Pellerino A; Garbossa D; Rudà R; Soffietti R
    Rev Neurol (Paris); 2023 Jun; 179(5):464-474. PubMed ID: 36990824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS Tumors - clinical and radiological aspects.
    Emmerová R; Engelová J; Vinakurau S; Ondrová B
    Cesk Patol; 2022; 58(3):150-160. PubMed ID: 36224037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosurgical management of metastases in the central nervous system.
    Claus EB
    Nat Rev Clin Oncol; 2011 Dec; 9(2):79-86. PubMed ID: 22143137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in managing brain metastasis.
    Kotecha R; Gondi V; Ahluwalia MS; Brastianos PK; Mehta MP
    F1000Res; 2018; 7():. PubMed ID: 30473769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of brain metastases.
    Soffietti R; Rudā R; Mutani R
    J Neurol; 2002 Oct; 249(10):1357-69. PubMed ID: 12382150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for brain metastases in patients with non-small-cell lung cancer.
    Taimur S; Edelman MJ
    Curr Oncol Rep; 2003 Jul; 5(4):342-6. PubMed ID: 12781078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Management of Central Nervous System Metastases from Breast Cancer.
    Avila J; Leone JP
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.
    Seastone DJ; Elson P; Garcia JA; Chao ST; Suh JH; Angelov L; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):111-6. PubMed ID: 24331575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
    Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
    J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
    Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
    Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resecting the dominant lesion: Patient outcomes after surgery and radiosurgery vs stand-alone radiosurgery in the setting of multiple brain metastases.
    Punchak M; Miranda SP; Gutierrez A; Brem S; O'Rourke D; Lee JYK; Shabason JE; Petrov D
    Clin Neurol Neurosurg; 2021 Dec; 211():107016. PubMed ID: 34823154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.